Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma

doi:10.1186/s40001-023-01575-9

Chia Nan University of Pharmacy & Science Institutional Repository > 行政單位 > 456 > Item 310902800/34799

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34799

標題:	Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
作者:	Ong, Khaa Hoo Lai, Hong-Yue Sun, Ding-Ping Chen, Tzu-Ju Huang, Steven Kuan-Hua Tian, Yu-Feng Chou, Chia-Lin Shiue, Yow-Ling Chan, Ti-Chun Li, Chien-Feng Kuo, Yu-Hsuan
貢獻者:	Chi Mei Med Ctr, Dept Surg, Div Gastroenterol & Gen Surg Chung Hwa Univ Med Technol, Dept Med Technol Natl Sun Yat Sen Univ, Inst Biomed Sci China Med Univ, Sch Med, Dept Pharmacol Chi Mei Med Ctr, Dept Clin Pathol Chi Mei Med Ctr, Dept Surg, Div Urol Chang Jung Christian Univ, Coll Hlth Sci, Dept Med Sci Ind Chi Mei Med Ctr, Dept Surg, Div Colon & Rectal Surg Natl Sun Yat Sen Univ, Inst Precis Med Chi Mei Med Ctr, Dept Internal Med, Div Hematol & Oncol Chi Mei Med Ctr, Dept Med Res Natl Hlth Res Inst, Natl Inst Canc Res Chi Mei Med Ctr, Trans Lab Precis Med Chia Nan Univ, Coll Pharm & Sci
關鍵字:	UBE2C Prognosis Cholangiocarcinoma Ubiquitination
日期:	2023
上傳時間:	2024-12-25 11:03:41 (UTC+8)
出版者:	BMC
摘要:	Cholangiocarcinoma is the most common malignant bile duct tumor in Southeast Asia. The special location of cholangiocarcinoma leads to it being difficult to diagnose. Currently, the progress in clinical prognosis outcomes remains abysmal owing to the lack of definitive diagnostic criteria. Therefore, uncovering the potential markers for cholangiocarcinoma is a pressing issue. Ubiquitin-conjugating enzyme E2 C (UBE2C) is a critical ubiquitination enzyme; it is involved in the tumorigenesis of various malignancies and affects the patient's prognosis. However, there is currently no relevant literature to indicate whether UBE2C is related to the clinical survival outcome of cholangiocarcinoma patients. In this report, we mined the published cholangiocarcinoma transcriptome data set (GSE26566), compared it with the ubiquitination-associated gene (GO:0016567), and identified that UBE2C was highly expressed in cholangiocarcinoma tumor tissue. Moreover, high expression of UBE2C was markedly correlated with surgical margin, primary tumor, histological variants, and histological grade. More specifically, high expression of UBE2C was negatively associated with overall survival, disease-specific survival, local recurrence-free survival, and metastasis-free survival in patients with cholangiocarcinoma. Our findings demonstrate that UBE2C may provide a potential therapeutic marker and prognostic factor for cholangiocarcinoma patients.
關聯:	European Journal of Medical Research, v.28, n.1, Article 593
顯示於類別:	[行政單位] 456

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	3	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....